MGNX
MacroGenics Inc
4.10$
+0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 178.3% | 97.4% | 141.0% | 94.7% | 317.4% | 314.9% | 197.6% | 3.5% | 4.9% | 14.4% | 8.3% | 28.9% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.5% | 95.1% | 85.6% | 91.7% | 71.1% | |
| 148.5% | 97.4% | 141.0% | 94.7% | 317.4% | 314.9% | 197.6% | 283.7% | 136.3% | 291.3% | 119.5% | 93.6% | |
| 33.7% | 22.6% | 34.5% | 21.0% | 67.4% | 74.3% | 43.7% | 83.3% | 38.8% | 91.2% | 47.9% | 26.2% | |
| 181.1% | 120.0% | 169.3% | 114.2% | 384.8% | 385.7% | 234.1% | 364.6% | 175.1% | 379.8% | 166.3% | 119.8% | |
| -81.1% | -20.0% | -69.3% | -14.2% | -284.8% | -285.7% | -134.1% | -268.1% | -79.9% | -294.2% | -74.5% | -48.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.9% | 0.2% | 2.5% | 0.8% | 5.7% | |
| -81.1% | -20.0% | -67.6% | -12.6% | -285.2% | -244.8% | -132.7% | -267.2% | -78.8% | -15.8% | -44.5% | -50.4% | |
| -3.9% | 0.0% | -8.8% | -4.6% | -0.4% | 17.2% | -12.2% | -14.9% | 0.2% | 16.6% | 0.6% | -0.4% | |
| -81.1% | -20.0% | -67.6% | -12.6% | -285.2% | -244.8% | -120.5% | -252.3% | -79.0% | -15.8% | -45.1% | -49.9% | |
| -77.2% | -17.2% | -60.6% | -9.6% | -269.5% | -265.8% | -121.8% | -253.2% | -72.1% | 3.5% | -38.7% | -39.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.